Literature DB >> 16172161

Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling.

Fabienne Baffert1, Tom Le, Barbara Sennino, Gavin Thurston, Calvin J Kuo, Dana Hu-Lowe, Donald M McDonald.   

Abstract

The vasculature of the embryo requires vascular endothelial growth factor (VEGF) during development, but most adult blood vessels lose VEGF dependence. However, some capillaries in the respiratory tract and selected other organs of adult mice regress after VEGF inhibition. The present study sought to identify the sequence of events and the fate of endothelial cells, pericytes, and vascular basement membrane during capillary regression in mouse tracheas after VEGF signaling was blocked with a VEGF-receptor tyrosine kinase inhibitor AG-013736 or soluble receptor construct (VEGF Trap or soluble adenoviral VEGFR-1). Within 1 day, patency was lost and fibrin accumulated in some tracheal capillaries. Apoptotic endothelial cells marked by activated caspase-3 were present in capillaries without blood flow. VEGF inhibition was accompanied by a 19% decrease in tracheal capillaries over 7 days and 30% over 21 days. During this period, desmin/NG2-immunoreactive pericytes moved away from regressing capillaries onto surviving vessels. Empty sleeves of basement membrane, left behind by regressing endothelial cells, persisted for about 2 wk and served as a scaffold for vascular regrowth after treatment ended. The amount of regrowth was limited by the number of surviving basement membrane sleeves. These findings demonstrate that, after inhibition of VEGF signaling, some normal capillaries regress in a systematic sequence of events initiated by a cessation of blood flow and followed by apoptosis of endothelial cells, migration of pericytes away from regressing vessels, and formation of empty basement membrane sleeves that can facilitate capillary regrowth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172161     DOI: 10.1152/ajpheart.00616.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  139 in total

1.  Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy.

Authors:  M J Koss; I Beger; F H Koch
Journal:  Eye (Lond)       Date:  2011-11-11       Impact factor: 3.775

2.  The mechanisms of cerebral vascular dysfunction and neuroinflammation by MMP-mediated degradation of VEGFR-2 in alcohol ingestion.

Authors:  P M Abdul Muneer; Saleena Alikunju; Adam M Szlachetka; James Haorah
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-08       Impact factor: 8.311

Review 3.  Tyrosine kinase inhibitor-induced hypothyroidism: incidence, etiology, and management.

Authors:  Rebecca L Brown
Journal:  Target Oncol       Date:  2011-11-19       Impact factor: 4.493

4.  Notch4 normalization reduces blood vessel size in arteriovenous malformations.

Authors:  Patrick A Murphy; Tyson N Kim; Gloria Lu; Andrew W Bollen; Chris B Schaffer; Rong A Wang
Journal:  Sci Transl Med       Date:  2012-01-18       Impact factor: 17.956

5.  Toward an in vitro vasculature: differentiation of mesenchymal stromal cells within an endothelial cell-seeded modular construct in a microfluidic flow chamber.

Authors:  Omar F Khan; M Dean Chamberlain; Michael V Sefton
Journal:  Tissue Eng Part A       Date:  2011-12-02       Impact factor: 3.845

Review 6.  Vascular endothelial growth factor biology: clinical implications for ocular treatments.

Authors:  R B Bhisitkul
Journal:  Br J Ophthalmol       Date:  2006-12       Impact factor: 4.638

7.  Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.

Authors:  Barbara Sennino; Beverly L Falcón; Dilara McCauley; Tom Le; Thomas McCauley; Jeffrey C Kurz; Amy Haskell; David M Epstein; Donald M McDonald
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 8.  Anti-vascular endothelial growth factor therapy for diabetic macular edema.

Authors:  David S Boyer; J Jill Hopkins; Jonathan Sorof; Jason S Ehrlich
Journal:  Ther Adv Endocrinol Metab       Date:  2013-12       Impact factor: 3.565

9.  Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain.

Authors:  Pouria Moshayedi; Lina R Nih; Irene L Llorente; Andrew R Berg; Jessica Cinkornpumin; William E Lowry; Tatiana Segura; S Thomas Carmichael
Journal:  Biomaterials       Date:  2016-08-02       Impact factor: 12.479

10.  Capillary defects and exaggerated inflammatory response in the airways of EphA2-deficient mice.

Authors:  Tatsuma Okazaki; Amy Ni; Peter Baluk; Oluwasheyi A Ayeni; Jennifer Kearley; Anthony J Coyle; Alison Humbles; Donald M McDonald
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.